Cargando…
Reactive perforating collagenosis successfully treated with dupilumab
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544964/ https://www.ncbi.nlm.nih.gov/pubmed/35633371 http://dx.doi.org/10.1111/ajd.13874 |
_version_ | 1784804715233542144 |
---|---|
author | Gil‐Lianes, Javier Riquelme‐Mc Loughlin, Constanza Mascaró, Jose Manuel |
author_facet | Gil‐Lianes, Javier Riquelme‐Mc Loughlin, Constanza Mascaró, Jose Manuel |
author_sort | Gil‐Lianes, Javier |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9544964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95449642022-10-14 Reactive perforating collagenosis successfully treated with dupilumab Gil‐Lianes, Javier Riquelme‐Mc Loughlin, Constanza Mascaró, Jose Manuel Australas J Dermatol Letters to the Editors John Wiley and Sons Inc. 2022-05-28 2022-08 /pmc/articles/PMC9544964/ /pubmed/35633371 http://dx.doi.org/10.1111/ajd.13874 Text en © 2022 The Authors. Australasian Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Australasian College of Dermatologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letters to the Editors Gil‐Lianes, Javier Riquelme‐Mc Loughlin, Constanza Mascaró, Jose Manuel Reactive perforating collagenosis successfully treated with dupilumab |
title | Reactive perforating collagenosis successfully treated with dupilumab |
title_full | Reactive perforating collagenosis successfully treated with dupilumab |
title_fullStr | Reactive perforating collagenosis successfully treated with dupilumab |
title_full_unstemmed | Reactive perforating collagenosis successfully treated with dupilumab |
title_short | Reactive perforating collagenosis successfully treated with dupilumab |
title_sort | reactive perforating collagenosis successfully treated with dupilumab |
topic | Letters to the Editors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544964/ https://www.ncbi.nlm.nih.gov/pubmed/35633371 http://dx.doi.org/10.1111/ajd.13874 |
work_keys_str_mv | AT gillianesjavier reactiveperforatingcollagenosissuccessfullytreatedwithdupilumab AT riquelmemcloughlinconstanza reactiveperforatingcollagenosissuccessfullytreatedwithdupilumab AT mascarojosemanuel reactiveperforatingcollagenosissuccessfullytreatedwithdupilumab |